NASDAQ:VKTX

Viking Therapeutics Stock Predictions

etoro logo Buy VKTX
*Your capital is at risk
$29.33
+0.0400 (+0.137%)
At Close: Jun 03, 2026
Currently predicting for Thu, 4 Jun 2026

VKTX Prediction Chart

VKTX Predictions History

Latest community submissions for VKTX.
Predictor Target Session Target Price Result Direction Accuracy Score
Aug 28, 2025 $25.96 -2.49% $27.58 X 94.11% 0
Aug 28, 2025 $75.00 +181.74% Unrealistic Excluded from avg $27.58 V 0.00% 1
Aug 28, 2025 Bullish $27.58 V 1
Aug 27, 2025 $24.95 -4.19% $26.62 X 93.72% 0
Aug 27, 2025 $26.72 +2.62% $26.62 V 99.62% 5
Aug 27, 2025 $34.00 +30.57% $26.62 V 72.28% 1
Aug 27, 2025 $34.00 +31.53% $26.62 V 72.28% 1
Aug 25, 2025 $27.18 +4.53% $25.85 X 94.86% 0
Aug 25, 2025 $26.74 +2.83% $25.85 X 96.57% 0
Aug 25, 2025 $46.00 +76.92% $25.85 X 22.05% 0
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for VKTX with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT VIKING THERAPEUTICS
Viking Therapeutics
Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. The company's lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß), which is in Phase IIb clinical trials to treat patients with biopsy-confirmed non-alcoholic steatohepatitis, as well as NAFLD. It also dev...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE